Abstract |
Hypoxia is a hallmark of pancreatic cancer (PC) and is associated with gemcitabine resistance. However, the mechanisms underlying hypoxia-induced gemcitabine resistance in PC remain greatly unknown. Our previous work showed that miR-301a, a hypoxia-sensitive miRNA, is involved in PC metastasis under hypoxia via regulation of its target gene P63. Here, we showed that miR-301a was upregulated in a NF-κB independent manner and promoted gemcitabine resistance under hypoxic conditions in vitro. In addition, TAp63, a member of the P63 family, reversed hypoxia-induced gemcitabine resistance by promoting degradation of HIF-1α. Furthermore, we proved that TAp63 was a functional downstream target of miR-301a and mediated the biological properties of miR-301a in PC. Taken together, these findings indicate that miR-301a exerts as a critical regulator involved in hypoxia-induced gemcitabine resistance in PC and may have potentials to be a therapeutic target for PC patients.
|
Authors | Guangtao Luo, Xiang Xia, Xiaofeng Wang, Kundong Zhang, Jun Cao, Tao Jiang, Qian Zhao, Zhengjun Qiu |
Journal | Experimental cell research
(Exp Cell Res)
Vol. 369
Issue 1
Pg. 120-128
(08 01 2018)
ISSN: 1090-2422 [Electronic] United States |
PMID | 29772221
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2018 Elsevier Inc. All rights reserved. |
Chemical References |
- MIRN301A microRNA, human
- MicroRNAs
- Deoxycytidine
- Gemcitabine
|
Topics |
- Apoptosis
(drug effects, genetics)
- Cell Proliferation
(drug effects, genetics)
- Deoxycytidine
(analogs & derivatives, therapeutic use)
- Drug Resistance, Neoplasm
(drug effects, genetics)
- Gene Expression Regulation, Neoplastic
(drug effects)
- HEK293 Cells
- Humans
- MicroRNAs
(physiology)
- Neoplasm Metastasis
- Pancreatic Neoplasms
(drug therapy, genetics, pathology)
- Tumor Cells, Cultured
- Tumor Hypoxia
(drug effects, genetics, physiology)
- Gemcitabine
|